AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 50 filers reported holding AVROBIO INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,291,655 | -47.4% | 2,412,015 | -44.7% | 0.09% | -49.1% |
| Q1 2023 | $4,357,859 | +84.7% | 4,357,859 | +31.7% | 0.17% | +56.9% |
| Q4 2022 | $2,359,598 | +5.1% | 3,309,859 | -5.3% | 0.11% | -21.6% |
| Q3 2022 | $2,245,000 | -30.2% | 3,494,490 | 0.0% | 0.14% | -31.9% |
| Q2 2022 | $3,215,000 | -6.1% | 3,494,490 | +34.7% | 0.20% | -5.1% |
| Q1 2022 | $3,425,000 | -65.7% | 2,594,914 | 0.0% | 0.22% | -72.1% |
| Q4 2021 | $9,990,000 | -16.1% | 2,594,914 | +21.6% | 0.77% | -26.6% |
| Q3 2021 | $11,903,000 | -37.2% | 2,133,214 | 0.0% | 1.05% | -25.8% |
| Q2 2021 | $18,964,000 | -4.4% | 2,133,214 | +36.5% | 1.42% | -2.8% |
| Q1 2021 | $19,828,000 | – | 1,562,476 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |